Uncategorized

Treating The Epidemic Of Loneliness And Social Isolation Among Seniors

One of the many lessons we should have learned from the Covid-19 pandemic is the cost to older adults of loneliness and social isolation. While nearly 900,000 older adults died from the virus, tens of thousands were sickened and may have died from the isolation the pandemic caused. But what have we learned from that tragic experience? Whether older adults [...]

By |2024-05-21T11:31:43-04:00May 21st, 2024|elder care, Health reform, Uncategorized|0 Comments

Changing The Way Doctors Talk To Patients About Dementia

Too often, physicians are reluctant to give patients a diagnosis of dementia, even when cognitive testing shows memory loss or other symptoms. And when doctors do provide a candid diagnosis, they may send their patients and their families home without any guidance for what to do next. No practical advice. No sense of hope. And too often, not even any [...]

By |2024-02-13T16:04:34-05:00February 12th, 2024|dementia, Uncategorized|0 Comments

For The First Time, Traditional Medicare Will Pay To Support Family Caregivers

The federal agency that operates Medicare, the Centers for Medicare and Medicaid Services (CMS), is finally recognizing what families have known for, well, thousands of years:  Family members are the bedrock of the system of care for frail older adults and younger people with disabilities. And the agency is taking some important steps to help them. Some proposals will provide [...]

By |2023-08-23T11:35:50-04:00August 23rd, 2023|family caregivers, Medicare, Uncategorized|0 Comments

The Quiet Struggles Of Those Living Alone With Memory Loss

Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important decisions, and you have no one by your side to support you, life can be extra tough. Researchers at the University of California San Francisco ((UCSF) estimate that about 4.3 million older adults with cognitive impairment [...]

By |2023-07-18T10:37:57-04:00July 18th, 2023|dementia, Uncategorized|0 Comments

FDA Has Approved The Anti-Alzheimer’s Drug Leqembi. What You Need To Know

The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers Eisai and Biogen. Here is what you need to know: What does it do? In a formal phase 3 trial, Leqembi was shown to slow the progression of memory loss and cognitive impairment in patients with early-stage Alzheimer’s disease by [...]

By |2023-07-06T17:25:34-04:00July 6th, 2023|dementia, Uncategorized|0 Comments

Why Are Care Delivery Models For People With Dementia Developing So Slowly?

Enormous attention is being given to controversial drugs aimed at slowing the progression of early-stage Alzheimer’s disease. Yet, a very different set of clinical innovations holds the promise of helping far more people living with dementia and their families in more immediate—and perhaps more effective—ways. These care delivery models are aimed at breaking down the often-impenetrable barriers between health care [...]

By |2023-06-27T10:36:59-04:00June 27th, 2023|dementia, Uncategorized|0 Comments

How The House GOPs Medicaid Work Rule Would Hurt Family Caregivers and People With Disabilities

The sponsors of the House Republican debt limit bill, the Limit, Save, Grow Act, say its goal is to encourage low-income people to work. But it may have exactly the opposite effect, especially for people with disabilities. And, at the same time, it may throw family caregivers into an impossible situation—having to choose between caring for their loved ones or [...]

By |2023-05-22T16:31:12-04:00May 22nd, 2023|Medicaid, Uncategorized|0 Comments

The US Predicts Big Increases In Skilled Nursing And Long-Term Care Costs

New government projections estimate significant increases in both overall and out-of-pocket costs for home care, nursing facilities, and continuing care communities (CCRCs) through this decade. The projected steep rise in costs will lead to tough decisions for both consumers and government. The latest annual projections, by analysts at the federal Centers for Medicare and Medicaid Services (CMS) forecast overall health [...]

By |2023-04-04T09:59:47-04:00April 4th, 2023|Health Care, Uncategorized|0 Comments

The FDA Approved The New Anti-Alzheimer’s Drug Leqembi. What You Need To Know

The FDA’s decision to grant accelerated approval for the anti-Alzheimer’s drug lecanemab, which will be sold as Leqembi, has significant potential for research into treatment of the disease. But people living with Alzheimer’s and their families will face difficult choices once the drug is made available later this month by Biogen and the Japanese firm Eisai. A trial found the [...]

By |2023-01-09T09:58:28-05:00January 9th, 2023|dementia, Uncategorized|0 Comments

Retirement Savings Bills Would Boost Deferred Annuities

When Congress returns for a short post-election session, one item on its to-do list is major retirement savings legislation that has broad bipartisan support. One feature of both House and Senate bills: Expanding a deferred annuity called a Qualified Longevity Annuity Contract (QLAC). Both bills would increase the allowable size of QLACs. That might make them more attractive to some [...]

By |2022-10-19T12:08:44-04:00October 19th, 2022|Uncategorized|0 Comments